Biomatrica, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States. Founded in 2006, the company has established itself as a pioneer in the preservation and storage of biological samples, catering to the needs of research institutions, biobanks, and pharmaceutical companies. Biomatrica's core offerings include advanced sample preservation solutions that utilise proprietary technologies, ensuring the integrity and viability of biological materials over extended periods. This unique approach sets them apart in the industry, enabling clients to maintain high-quality samples for various applications, including diagnostics and drug development. With a strong market position, Biomatrica has achieved significant milestones, including partnerships with prominent research organisations and recognition for its contributions to biobanking. The company continues to drive innovation, solidifying its reputation as a trusted partner in the life sciences field.
How does Biomatrica, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biomatrica, Inc.'s score of 41 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biomatrica, Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Exact Sciences Corporation, which may influence its climate commitments and performance metrics. As part of its corporate family, Biomatrica may align with the sustainability initiatives and targets set by Exact Sciences Corporation. However, specific reduction targets or achievements related to carbon emissions have not been disclosed for Biomatrica itself. The absence of documented reduction initiatives or climate pledges suggests that the company may still be in the process of establishing its own climate strategy. Given the lack of direct emissions data and reduction commitments, it is essential for Biomatrica to develop and communicate its climate action plans to enhance transparency and accountability in its environmental impact.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | - | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 161,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | 3,540,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 |
Biomatrica, Inc.'s Scope 3 emissions, which decreased by 19% last year and increased by approximately 96% since 2019, demonstrating supply chain emissions tracking. A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 36% of total emissions under the GHG Protocol, with "Business Travel" being the largest emissions source at 72% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biomatrica, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.